Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Roberts

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Rheumatology (Oxford, England)|June 23, 1999
Probucol improves symptoms and reduces lipoprotein oxidation susceptibility in patients with Raynaud's phenomenonC P Denton, T D Bunce, M B Dorado, et al.
The International Journal of Neuropsychopharmacology|August 2, 2021
HIV Transgenic Rats Demonstrate Impaired Sensorimotor Gating But Are Insensitive to Cannabinoid (Δ9-Tetrahydrocannabinol)-Induced DeficitsBenjamin Z Roberts, Arpi Minassian, Adam L Halberstadt, et al.
Cell Reports|August 17, 2022
A central alarm system that gates multi-sensory innate threat cues to the amygdalaSukjae J Kang, Shijia Liu, Mao Ye, et al.
Cell Death Discovery|July 28, 2020
Pevonedistat (MLN4924): mechanism of cell death induction and therapeutic potential in colorectal cancerJennifer Ferris, Margarita Espona-Fiedler, Claudia Hamilton, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 22, 2020
Memantine effects on auditory discrimination and training in schizophrenia patientsNeal R Swerdlow, Savita G Bhakta, Jo Talledo, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 19, 2022
EEG reveals that dextroamphetamine improves cognitive control through multiple processes in healthy participantsSavita G Bhakta, James F Cavanagh, Jo A Talledo, et al.
Cognitive, Affective & Behavioral Neuroscience|January 3, 2024
Amphetamine increases motivation of humans and mice as measured by breakpoint, but does not affect an Electroencephalographic biomarkerMichael Noback, Savita G Bhakta, Jo A Talledo, et al.
EMBO Reports|February 4, 2020
A revised model of TRAIL-R2 DISC assembly explains how FLIP(L) can inhibit or promote apoptosisLuke M Humphreys, Jennifer P Fox, Catherine A Higgins, et al.
Translational Psychiatry|November 27, 2025
Chronic cannabis use in people with bipolar disorder is associated with comparable decision-making and functional outcome to healthy participantsAlannah Miranda, Benjamin Z Roberts, Breanna M Holloway, et al.
Psychopharmacology|February 8, 2022
Amphetamine alters an EEG marker of reward processing in humans and miceJames F Cavanagh, Sarah L Olguin, Jo A Talledo, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Rheumatology (Oxford, England)|June 23, 1999
Probucol improves symptoms and reduces lipoprotein oxidation susceptibility in patients with Raynaud's phenomenonC P Denton, T D Bunce, M B Dorado, et al.
The International Journal of Neuropsychopharmacology|August 2, 2021
HIV Transgenic Rats Demonstrate Impaired Sensorimotor Gating But Are Insensitive to Cannabinoid (Δ9-Tetrahydrocannabinol)-Induced DeficitsBenjamin Z Roberts, Arpi Minassian, Adam L Halberstadt, et al.
Cell Reports|August 17, 2022
A central alarm system that gates multi-sensory innate threat cues to the amygdalaSukjae J Kang, Shijia Liu, Mao Ye, et al.
Cell Death Discovery|July 28, 2020
Pevonedistat (MLN4924): mechanism of cell death induction and therapeutic potential in colorectal cancerJennifer Ferris, Margarita Espona-Fiedler, Claudia Hamilton, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 22, 2020
Memantine effects on auditory discrimination and training in schizophrenia patientsNeal R Swerdlow, Savita G Bhakta, Jo Talledo, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 19, 2022
EEG reveals that dextroamphetamine improves cognitive control through multiple processes in healthy participantsSavita G Bhakta, James F Cavanagh, Jo A Talledo, et al.
Cognitive, Affective & Behavioral Neuroscience|January 3, 2024
Amphetamine increases motivation of humans and mice as measured by breakpoint, but does not affect an Electroencephalographic biomarkerMichael Noback, Savita G Bhakta, Jo A Talledo, et al.
EMBO Reports|February 4, 2020
A revised model of TRAIL-R2 DISC assembly explains how FLIP(L) can inhibit or promote apoptosisLuke M Humphreys, Jennifer P Fox, Catherine A Higgins, et al.
Translational Psychiatry|November 27, 2025
Chronic cannabis use in people with bipolar disorder is associated with comparable decision-making and functional outcome to healthy participantsAlannah Miranda, Benjamin Z Roberts, Breanna M Holloway, et al.
Psychopharmacology|February 8, 2022
Amphetamine alters an EEG marker of reward processing in humans and miceJames F Cavanagh, Sarah L Olguin, Jo A Talledo, et al.
Pageof 5